English
Structure via PubChem · Public domain (PubChem)
(+)-emtricitabine
Sign in to saveRacivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
Chemical data
- Formula
- C8H10FN3O3S
- Molecular weight
- 247.25 g/mol
- IUPAC name
- 4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
- SMILES
- C1[C@@H](O[C@@H](S1)CO)N2C=C(C(=NC2=O)N)F
- InChIKey
- XQSPYNMVSIKCOC-RITPCOANSA-N
- XLogP
- -0.6
- Polar surface area
- 113 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Mass
- 247.043
Show 4 more facts
- chemical formula
- C₈H₁₀FN₃O₃S
- canonical SMILES
- C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F
- isomeric SMILES
- C1[C@@H](O[C@@H](S1)CO)N2C=C(C(=NC2=O)N)F
- Commons category
- Racivir
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Racivir is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
thumb|left|Emtricitabine, the [[enantiomer of racivir and a widely used NRTI]]
Excerpted from Wikipedia’s “(+)-emtricitabine” article, available under the CC BY-SA 4.0 licence.